221 related articles for article (PubMed ID: 30872612)
21. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts.
Makino K; Jinnin M; Aoi J; Hirano A; Kajihara I; Makino T; Sakai K; Fukushima S; Inoue Y; Ihn H
J Invest Dermatol; 2013 Jan; 133(1):110-9. PubMed ID: 22832484
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
23. Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.
Hirabayashi M; Asano Y; Yamashita T; Miura S; Nakamura K; Taniguchi T; Saigusa R; Takahashi T; Ichimura Y; Miyagawa T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2018 Feb; 45(2):182-188. PubMed ID: 29044628
[TBL] [Abstract][Full Text] [Related]
24. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis.
Teng L; Yao G; Gao R; Wang Y; Lin W; Jin Y; Wang Y; Chen H; Wang Z; Chen J
Eur J Dermatol; 2019 Aug; 29(4):359-365. PubMed ID: 31625918
[TBL] [Abstract][Full Text] [Related]
25. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis.
Cipriani P; Ruscitti P; Di Cola I; Vomero M; Abbruzzese F; Di Nino E; Ross R; Del Galdo F; Giacomelli R
Rheumatology (Oxford); 2023 Mar; 62(3):1317-1325. PubMed ID: 35916713
[TBL] [Abstract][Full Text] [Related]
27. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus.
Zhou Q; Yu B; Anderson C; Huang ZP; Hanus J; Zhang W; Han Y; Bhattacharjee PS; Srinivasan S; Zhang K; Wang DZ; Wang S
Elife; 2019 Feb; 8():. PubMed ID: 30741632
[TBL] [Abstract][Full Text] [Related]
28. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
29. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of scleroderma fibroblast clonal cell lines by introduction of the hTERT gene.
Kapanadze B; Morris E; Smith E; Trojanowska M
J Cell Mol Med; 2010 May; 14(5):1156-65. PubMed ID: 19432820
[TBL] [Abstract][Full Text] [Related]
31. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the phenotype of high collagen-producing fibroblast clones in systemic sclerosis, using a new modified limiting-dilution method.
Zhu L; Gao D; Yang J; Li M
Clin Exp Dermatol; 2012 Jun; 37(4):395-403. PubMed ID: 22582912
[TBL] [Abstract][Full Text] [Related]
33. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
34. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
Iwamoto N; Vettori S; Maurer B; Brock M; Pachera E; Jüngel A; Calcagni M; Gay RE; Whitfield ML; Distler JH; Gay S; Distler O
Ann Rheum Dis; 2016 Jan; 75(1):303-10. PubMed ID: 25384965
[TBL] [Abstract][Full Text] [Related]
36. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
37. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
[TBL] [Abstract][Full Text] [Related]
38. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
39. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts.
Ueda-Hayakawa I; Hasegawa M; Hamaguchi Y; Takehara K; Fujimoto M
J Dermatol Sci; 2013 Jan; 69(1):54-60. PubMed ID: 23159281
[TBL] [Abstract][Full Text] [Related]
40. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]